Med Page Today

DECEMBER 21, 2023

(MedPage Today) -- For patients undergoing catheter ablation for atrial fibrillation (Afib), there was no signal that a brief course of colchicine reduced atrial arrhythmia recurrence or improved clinical outcomes when taken for 10 days starting.

Arrhythmia 113

Arrhythmia Ablation AFIB Atrial Fibrillation 113

DAIC

APRIL 18, 2024

Based on continuous monitoring of early recurrence of atrial tachyarrhythmia immediately after patients have undergone atrial fibrillation ablation, Musat et al. However, this reasoning disregards valuable data regarding early arrhythmia recurrences and their potential significance.

Atrial Fibrillation 111

Atrial Fibrillation Ablation Heart Rhythm Article 111

DAIC

DECEMBER 29, 2023

Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF.

Atrial Fibrillation 115

Atrial Fibrillation Ablation Atrial Flutter Blood Clot 115

Frontiers in Cardiovascular Medicine

FEBRUARY 5, 2025

IntroductionAtrial fibrillation (AF) is a prevalent cardiac arrhythmia and a significant contributor to cardioembolic stroke, a condition closely linked to cognitive decline. However, research reveals that AF itself is independently associated with an increased risk of cognitive impairment.

Atrial Fibrillation 52

Atrial Fibrillation Arrhythmia Ablation Research 52

Frontiers in Cardiovascular Medicine

JANUARY 16, 2024

Introduction Catheter ablation is an effective and safe strategy for treating atrial fibrillation patients. Nevertheless, studies on the long-term outcomes of catheter ablation in patients with dilated cardiomyopathy are limited. Among the catheter ablation group, 58.7% ( n  = 27) had persistent atrial fibrillation.

Atrial Fibrillation 64

Atrial Fibrillation Cardiomyopathy Ablation Heart Failure 64

HeartRhythm

MARCH 31, 2025

IV lidocaine is used to treat refractory ventricular arrhythmia (VA). In patients with heart failure (HF), atrial fibrillation (AF) is common and can further compromise hemodynamic and electrical stability. There is little data describing clinical outcomes of patients with HF, AF, and VA receiving lidocaine.

Atrial Fibrillation 40

Atrial Fibrillation Heart Failure Arrhythmia Outcomes 40

HeartRhythm

MARCH 31, 2025

Cardiomyopathy (CM) is associated with arrhythmias, resulting in considerable morbidity and mortality. Atrial fibrillation (AF) is a common arrhythmia linked to adverse outcomes, yet mortality trends between AF and other arrhythmias (OA) in patients with CM remain understudied.

Atrial Fibrillation 40

Atrial Fibrillation Arrhythmia Cardiomyopathy Outcomes 40

Cardiomatics

APRIL 5, 2024

By understanding the nuances of abnormalities detected in Cardiomatics and interpreting detailed reports, healthcare professionals can intervene promptly to prevent adverse outcomes. AFIB/AFL – atrial fibrillation or atrial flutter episodes. 1] Arrhythmia Recognition: The Art of Interpretation, T.Garcia, D.Garcia.

Arrhythmia 92

Arrhythmia Tachycardia Bradycardia Heart Rhythm 92

HeartRhythm

MARCH 31, 2025

The rising prevalence of atrial fibrillation (AF) is a pressing concern directly tied to severe cardiovascular morbidity and mortality. Cardiac arrest (CA), which can stem from AF and other arrhythmias (OAs), plays a crucial role in escalating overall mortality rates.

Cardiac Arrest 40

Cardiac Arrest Atrial Fibrillation Arrhythmia Public Health 40

Frontiers in Cardiovascular Medicine

JULY 31, 2024

Atrial fibrillation (AF) represents the most common cardiac arrhythmia with significant morbidity and mortality implications. This review aims to analyze the existing literature on the effects of dietary modifications on the incidence, progression, and outcomes of atrial fibrillation.

Atrial Fibrillation 52

Atrial Fibrillation Quality of Life Diet Arrhythmia 52

HeartRhythm

MARCH 31, 2025

Atrial fibrillation(AF) is the most common sustained arrhythmia in hypertrophic cardiomyopathy(HCM). AF in HCM increased the risk of morbidity and mortality and patients with HCM and AF have worse clinical outcomes than those without AF.

Atrial Fibrillation 40

Atrial Fibrillation Cardiomyopathy Outcomes Arrhythmia 40

HeartRhythm

APRIL 30, 2024

Atrial fibrillation is the most common sustained arrhythmia. Females with atrial fibrillation have been known to have an increased risk of stroke. However, racial disparities in outcomes in atrial fibrillation patients have been less studied.

Atrial Fibrillation 40

Atrial Fibrillation Outcomes Hospital Arrhythmia 40

Frontiers in Cardiovascular Medicine

JANUARY 31, 2024

Background Pulmonary vein isolation with wide antral ablation leads to better clinical outcomes for the treatment of atrial fibrillation, but the isolation lesion is invisible in conventional cryoballoon ablation. The rate of 12-month freedom from clinical atrial arrhythmia recurrence was 85.1% min, P  = 0.177).

Atrial Fibrillation 64

Atrial Fibrillation Ablation Pulmonary Outcomes 64

HeartRhythm

MARCH 31, 2025

Freedom from 30 second arrhythmia recurrence remains an accurate tool to compare atrial fibrillation (AF) ablation outcome.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outcomes Arrhythmia 40

HeartRhythm

APRIL 30, 2024

Atrial fibrillation (AF) is the most common arrhythmia in clinical practice and accounts for many arrhythmia-related hospitalizations. Despite being on anticoagulation (AC), male patients with atrial fibrillation have worse inpatient outcomes compared to females.

Atrial Fibrillation 40

Atrial Fibrillation Inpatient Outcomes Arrhythmia 40

American College of Cardiology

FEBRUARY 19, 2025

In this weeks View, Dr. Eagle looks at arrhythmia recurrence and rhythm control after catheter ablation for atrial fibrillation. He then discusses long-term outcomes in transthyretin amyloid cardiomyopathy in patients treated with tafamidis.

Arrhythmia 54

Arrhythmia Cardiomyopathy Ablation AFIB 54

Open Heart

JANUARY 18, 2024

Introduction Three recent randomised controlled trials have demonstrated that pulmonary vein isolation as an initial rhythm control strategy with cryoablation reduces atrial arrhythmia recurrence in patients with symptomatic paroxysmal atrial fibrillation (PAF) compared with antiarrhythmic drug (AAD) therapy.

Atrial Fibrillation 69

Atrial Fibrillation Ablation Pulmonary Arrhythmia 69

HeartRhythm

MARCH 31, 2025

Atypical atrial flutter (AtFL) and atrial fibrillation (AF) share similar clinical presentations but may differ in underlying substrates and clinical progression.

Atrial Flutter 40

Atrial Flutter Atrial Fibrillation Arrhythmia Outcomes 40

HeartRhythm

MARCH 31, 2025

Atrial fibrillation (AF) is a common cardiac arrhythmia linked to significant morbidity and mortality and AF ablation has shown benefits for racial minorities.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Arrhythmia Outcomes 40

Frontiers in Cardiovascular Medicine

DECEMBER 14, 2023

Typical atrial flutter commonly occurs in patients with atrial fibrillation (AF). Limited information exists regarding the effects of concurrent atrial flutter on the long-term outcomes of rhythm control. Patients who were screened for typical atrial flutter were included in the analysis ( n  = 1,907).

Atrial Flutter 64

Atrial Flutter Atrial Fibrillation Ablation Arrhythmia 64

HeartRhythm

MARCH 31, 2025

Atrial fibrillation (AF) is the most prevalent sustained arrhythmia, but its diagnosis is often elusive. Diagnosing AF has important clinical implications to patients management and outcomes.

Atrial Fibrillation 40

Atrial Fibrillation Arrhythmia Outcomes 40

Frontiers in Cardiovascular Medicine

OCTOBER 9, 2024

The primary outcome was ventricular arrhythmias, the secondary outcomes were bradycardia and atrial fibrillation (AF).ResultsOur Perioperative or postoperative use of DEX reduced the incidence of in-hospital ventricular arrhythmias [Odds Ratio (OR) 0.14, 95% Confidence Interval (CI) 0.03–0.66],

Arrhythmia 52

Arrhythmia Bradycardia Atrial Fibrillation Hospital 52

HeartRhythm

MARCH 31, 2025

Atrial fibrillation (AF) is among the most prevalent arrhythmias. Evidence suggests that rhythm control offers superior cardiovascular outcomes in persistent AF compared to rate control. Catheter ablation has demonstrated greater efficacy than antiarrhythmic medications in preventing AF recurrence.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Risk Factors Arrhythmia 40

HeartRhythm

MARCH 31, 2025

The outcome of ablation in persistent atrial fibrillation (AF) has been modest despite adding linear ablation or substrate modification. Hybrid AF ablation is being emerged as an alternative to endocardial ablation. Comparative studies are characterised by limited sample size, diverse results and variations in lesions set.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Arrhythmia Outcomes 40

HeartRhythm

MARCH 31, 2025

Catheter ablation via pulmonary vein isolation (PVI) is first-line treatment for paroxysmal atrial fibrillation (pAF). It is unclear whether additional lesions with PVI using the novel pulsed field ablation (PFA) technique affects outcomes in this population.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Arrhythmia Pulmonary 40

DAIC

FEBRUARY 2, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , revealed findings from a company-funded study of real-world data. AFib is the most common type of cardiac arrhythmia and affects more than 6 million people in the United States and nearly 38 million people worldwide.2,3 In: AF Symposium.;

Ablation 105

Ablation Atrial Fibrillation AFIB Heart Rhythm 105

HeartRhythm

APRIL 30, 2024

The introduction of Bruton Tyrosine Kinase inhibitors (BTKi) to the Chronic Lymphocytic Leukemia (CLL) treatment armamentarium has facilitated a significant improvement in overall outcomes. Incident atrial fibrillation (AF) has been identified as the most common reason for discontinuation of BTKi, limiting therapeutic utility of these agents.

Atrial Fibrillation 40

Atrial Fibrillation Arrhythmia Stroke Strokes 40

HeartRhythm

MARCH 31, 2025

Patients with hypertrophic cardiomyopathy (HCM) undergoing atrial fibrillation (AF) ablation have less favorable outcomes than those without HCM. However, previous studies have limited sample size to assess arrhythmia mechanism and intraprocedural findings during repeat ablation procedures in patients with HCM.

Atrial Fibrillation 40

Atrial Fibrillation Cardiomyopathy Ablation Arrhythmia 40

HeartRhythm

MARCH 31, 2025

Atrial fibrillation (AF) is the most prevalent sustained arrhythmia in patients with cardiac amyloidosis (CA). Diastolic and microvascular dysfunction from amyloid deposition in CA causes adverse myocardial remodeling, frequently resulting in the progression to persistent atrial fibrillation (PsAF).

Atrial Fibrillation 40

Atrial Fibrillation Arrhythmia Ablation Outcomes 40

HeartRhythm

APRIL 30, 2024

Atrial Fibrillation (AF) is the most common arrhythmia associated with hospital admissions in the United States. Recent guidelines advocate for early rhythm control in this population, however, there is little information regarding early electrophysiologist intervention and resulting patient outcomes.

Atrial Fibrillation 40

Atrial Fibrillation Hospital Outcomes Arrhythmia 40

Frontiers in Cardiovascular Medicine

JANUARY 15, 2024

Background Catheter ablation (CA) for symptomatic atrial fibrillation (AF) offers the best outcomes for patients. The probability of freedom from atrial arrhythmia with repeat procedures is as follows: year 1: 0.95, year 2: 0.92, year 3: 0.85, year 4: 0.79, and year 5: 0.72. Age >75 years ( p  = 0.02, HR: 2.7,

Ablation 64

Ablation Atrial Fibrillation BMI Arrhythmia 64

HeartRhythm

APRIL 30, 2024

Atrial fibrillation (AF) is the most common cardiac arrhythmia. Catheter ablation (CA) has emerged as an important modality for managing AF, improving quality of life, and potentially reversing cardiac dysfunction.

Atrial Fibrillation 40

Atrial Fibrillation Quality of Life Ablation Arrhythmia 40

HeartRhythm

MARCH 31, 2025

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in adults, leading to significant cardiovascular complications such as ischemic stroke, heart failure, and myocardial infarction. Pulmonary vein isolation (PVI) is a well-established treatment for rhythm control in patients with AF.

Atrial Fibrillation 40

Atrial Fibrillation Pulmonary Myocardial Infarction Heart Failure 40

HeartRhythm

MARCH 31, 2025

Pulsed field ablation (PFA) is a promising new alternative to thermal ablation (TA) for atrial fibrillation (AF), improving safety and duration of procedure times. Understanding its role in PFA is critical for optimizing procedural efficiency and long-term outcomes.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Arrhythmia Pulmonary 40

HeartRhythm

MARCH 31, 2025

Whilst pulmonary vein isolation (PVI) is the key endpoint for catheter ablation therapy for atrial fibrillation (AF), it is unknown whether adjunctive carinal ablation impacts outcome beyond achieving first pass isolation.

Atrial Fibrillation 40

Atrial Fibrillation Pulmonary Ablation Arrhythmia 40

HeartRhythm

JANUARY 6, 2025

Atrial fibrillation (AF) is a common arrhythmia in patients with heart failure (HF). The coexistence of these conditions can further induce structural changes and result in worsened outcomes such as stroke, HF decompensation, poorly controlled AF, and mortality [1].

Preserved Ejection Fraction 40

Preserved Ejection Fraction Heart Failure Atrial Fibrillation Ablation 40

HeartRhythm

AUGUST 13, 2024

Atrial arrhythmias (AA), particularly atrial fibrillation (AF), are prevalent in CA and may impact long-term cardiovascular outcomes, prompting an investigation into early rhythm management strategies.2 1 Recent advancements in imaging and therapeutic agents have sparked considerable interest in this field.

Arrhythmia 40

Arrhythmia Ablation Outcomes Atrial Fibrillation 40